BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12804633)

  • 1. The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype.
    Zent CS; Zhan F; Schichman SA; Bumm KH; Lin P; Chen JB; Shaughnessy JD
    Leuk Res; 2003 Sep; 27(9):765-74. PubMed ID: 12804633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Best OG; Almazi JG; Belov L; Davis ZA; Majid A; Dyer MJ; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2014 Sep; 55(9):2085-92. PubMed ID: 24289109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia.
    Dürig J; Nückel H; Hüttmann A; Kruse E; Hölter T; Halfmeyer K; Führer A; Rudolph R; Kalhori N; Nusch A; Deaglio S; Malavasi F; Möröy T; Klein-Hitpass L; Dührsen U
    Blood; 2003 Apr; 101(7):2748-55. PubMed ID: 12456497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
    Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
    Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
    Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL
    Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
    Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H
    Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection.
    Garcia Vela J; Delgado I; Benito L; Monteserin M; Garcia Alonso L; Somolinos N; Andreu M; Oña F
    Leukemia; 1999 Oct; 13(10):1501-5. PubMed ID: 10516749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD52 is not a promising immunotherapy target for most patients with multiple myeloma.
    Westermann J; Maschmeyer G; van Lessen A; Dörken B; Pezzutto A
    Int J Hematol; 2005 Oct; 82(3):248-50. PubMed ID: 16207599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
    Hulkkonen J; Vilpo L; Hurme M; Vilpo J
    Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.
    Kroft SH; Dawson DB; McKenna RW
    Am J Clin Pathol; 2001 Mar; 115(3):385-95. PubMed ID: 11242795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL.
    Kriston C; Bödör C; Szenthe K; Bánáti F; Bánkuti B; Csernus B; Reiniger L; Csomor J; Matolcsy A; Barna G
    Hematol Oncol; 2017 Mar; 35(1):58-63. PubMed ID: 26119874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells.
    Vilpo J; Hulkkonen J; Hurme M; Vilpo L
    Leukemia; 2002 Sep; 16(9):1691-8. PubMed ID: 12200683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
    Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
    Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia.
    Maďarová M; Mucha R; Hresko S; Makarová Z; Gdovinová Z; Szilasiová J; Vitková M; Guman T; Štecová N; Dobransky T
    Leuk Res; 2018 Jul; 70():25-33. PubMed ID: 29763855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts.
    Rawstron AC; Green MJ; Kuzmicki A; Kennedy B; Fenton JA; Evans PA; O'Connor SJ; Richards SJ; Morgan GJ; Jack AS; Hillmen P
    Blood; 2002 Jul; 100(2):635-9. PubMed ID: 12091358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal B lymphocytosis versus chronic lymphocytic leukemia: factors affecting implementation of an absolute threshold.
    Rollins-Raval MA; Fisher J; Craig FE
    Cytometry B Clin Cytom; 2013 May; 84(3):149-56. PubMed ID: 23475845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly purified CD38+ and CD38- sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin.
    Pepper C; Ward R; Lin TT; Brennan P; Starczynski J; Musson M; Rowntree C; Bentley P; Mills K; Pratt G; Fegan C
    Leukemia; 2007 Apr; 21(4):687-96. PubMed ID: 17287849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype.
    Segel GB; Woodlock TJ; Xu J; Li L; Felgar RE; Ryan DH; Lichtman MA; Wang N
    Blood Cells Mol Dis; 2003; 30(3):277-87. PubMed ID: 12737946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.